How do you approach treatment of metastatic disease involving the brainstem or cervical spinal cord in the setting of prior XRT?

I would look at this scenario taking into account, not limited to, the overall life expectancy of the patient, performance status, cranial and extracranial disease control. I would want to know the prior RT dose fraction, overlap with current target volume, and interval from the prior RT. Suppose th...